Mark W.C. Hatton

1.1k total citations
46 papers, 850 citations indexed

About

Mark W.C. Hatton is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Mark W.C. Hatton has authored 46 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Hematology. Recurrent topics in Mark W.C. Hatton's work include Blood properties and coagulation (11 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Mark W.C. Hatton is often cited by papers focused on Blood properties and coagulation (11 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Mark W.C. Hatton collaborates with scholars based in Canada, United States and Austria. Mark W.C. Hatton's co-authors include E. Regoeczi, Leslie R. Berry, Mary Richardson, Frederick A. Spencer, Joel M. Gore, Robert J. Goldberg, Jorge Yarzebski, Theo E. Meyer, Darleen Lessard and J. Philip Thornber and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and Biochemistry.

In The Last Decade

Mark W.C. Hatton

46 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W.C. Hatton Canada 15 363 197 134 107 98 46 850
Yuichi Nakamura Japan 18 393 1.1× 123 0.6× 242 1.8× 103 1.0× 184 1.9× 62 1.0k
James Lawrence United States 13 393 1.1× 121 0.6× 72 0.5× 30 0.3× 84 0.9× 23 1.0k
Arkadiusz Bonna Poland 19 403 1.1× 129 0.7× 182 1.4× 97 0.9× 74 0.8× 47 1.1k
Alfredo Colonna Italy 17 303 0.8× 121 0.6× 180 1.3× 67 0.6× 66 0.7× 30 882
Jimmy D. Page United States 14 310 0.9× 135 0.7× 329 2.5× 67 0.6× 80 0.8× 20 981
Nancy S. Nicholson United States 18 181 0.5× 270 1.4× 402 3.0× 50 0.5× 167 1.7× 34 905
Alexander Nakeff United States 17 326 0.9× 49 0.2× 389 2.9× 127 1.2× 62 0.6× 56 936
R. Pescador Italy 14 167 0.5× 118 0.6× 191 1.4× 43 0.4× 118 1.2× 56 654
Guey‐Yueh Shi Taiwan 15 288 0.8× 89 0.5× 261 1.9× 70 0.7× 62 0.6× 35 771
J.C. Mazière France 18 339 0.9× 34 0.2× 60 0.4× 206 1.9× 86 0.9× 37 979

Countries citing papers authored by Mark W.C. Hatton

Since Specialization
Citations

This map shows the geographic impact of Mark W.C. Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W.C. Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W.C. Hatton more than expected).

Fields of papers citing papers by Mark W.C. Hatton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W.C. Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W.C. Hatton. The network helps show where Mark W.C. Hatton may publish in the future.

Co-authorship network of co-authors of Mark W.C. Hatton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W.C. Hatton. A scholar is included among the top collaborators of Mark W.C. Hatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W.C. Hatton. Mark W.C. Hatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Mary, et al.. (2006). Turnover and fate of fibrinogen and platelets at the rabbit aorta wall immediately after a balloon de-endothelializing injury in vivo. Thrombosis and Haemostasis. 96(7). 60–67. 2 indexed citations
2.
Berry, Leslie R., Nagina Parmar, Mark W.C. Hatton, & Anthony K.C. Chan. (2006). Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity. Biochemical and Biophysical Research Communications. 346(3). 946–957. 1 indexed citations
3.
Hatton, Mark W.C., Kimberly Legault, Darren Korbie, et al.. (2002). Angiostatin II is the predominant glycoform in pleural effusates of rabbit VX-2 lung tumors. Journal of Laboratory and Clinical Medicine. 139(5). 316–323. 10 indexed citations
6.
Hatton, Mark W.C., et al.. (2000). Metabolism and distribution of the virus-encoded serine proteinase inhibitor SERP-1 in healthy rabbits. Metabolism. 49(11). 1449–1452. 6 indexed citations
8.
Hatton, Mark W.C., et al.. (1999). Uptake of heparin cofactor II and antithrombin into the aorta wall after a deendothelializing injury in vivo: Comparison with the behaviors of prothrombin and fibrinogen. Journal of Laboratory and Clinical Medicine. 133(1). 81–87. 6 indexed citations
9.
Spencer, Frederick A., Theo E. Meyer, Robert J. Goldberg, et al.. (1999). Twenty year trends (1975–1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction. Journal of the American College of Cardiology. 34(5). 1378–1387. 160 indexed citations
10.
11.
Hatton, Mark W.C., et al.. (1997). Cytokeratin 18 Is Expressed on the Hepatocyte Plasma Membrane Surface and Interacts with Thrombin-Antithrombin Complexes. Journal of Biological Chemistry. 272(45). 28574–28581. 63 indexed citations
12.
Hatton, Mark W.C., et al.. (1997). Comparative catabolism of prothrombin and antithrombin in normal and alloxan-diabetic rabbits. Metabolism. 46(12). 1406–1411. 1 indexed citations
13.
Hatton, Mark W.C., Mary Richardson, & P.D. Winocour. (1993). On Glucose Transport and Non-enzymic Glycation of Proteins In Vivo. Journal of Theoretical Biology. 161(4). 481–490. 16 indexed citations
14.
Richardson, Mary & Mark W.C. Hatton. (1993). Transient Morphological and Biochemical Alterations of Arterial Proteoglycan during Early Wound Healing. Experimental and Molecular Pathology. 58(2). 77–95. 3 indexed citations
15.
Hatton, Mark W.C., et al.. (1988). Evidence that Rabbit <sup>125</sup>I-Antithrombin III Binds to Proteoheparan Sulphate at the Subendothelium of the Rabbit Aorta in vitro. Journal of Vascular Research. 25(1). 12–27. 19 indexed citations
16.
Winocour, P.D., R L Kinlough-Rathbone, Margaret L. Rand, Mark W.C. Hatton, & J. F. Mustard. (1988). Thrombin binding to platelets from hypercholesterolaemic rats. Atherosclerosis. 73(2-3). 215–221. 6 indexed citations
17.
Hatton, Mark W.C. & Leslie R. Berry. (1987). A comparison of two procedures used for complexing Fe(III) with human apotransferrin. II. Uptake of Fe(III) by K-562 cells from 55Fe∙transferrins and Fe∙[3H]transferrins. Biochemistry and Cell Biology. 65(4). 271–279. 2 indexed citations
18.
Hatton, Mark W.C. & Leslie R. Berry. (1984). Location of bi- and tri-antennary N-glycans among the heterogeneous forms of human serum transferrin: a topographical study. Biochemical Society Transactions. 12(2). 293–294. 5 indexed citations
19.
Berry, Leslie R. & Mark W.C. Hatton. (1983). Controlled depolymerization of heparin: Anticoagulant activity and molecular size of the products. Biochemical Society Transactions. 11(1). 101–102. 2 indexed citations
20.
Hatton, Mark W.C., et al.. (1983). On the significance of heterogeneity of plasma glycoproteins possessing N -glycans of the complex type: a perspective. Trends in Biochemical Sciences. 8(8). 287–291. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026